Financial reports
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
10-Q
2021 Q1
Quarterly report
7 May 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
Current reports
8-K
Bankruptcy or Receivership
13 Jun 23
8-K
Bankruptcy or Receivership
25 May 23
8-K
Regulation FD Disclosure
26 Apr 23
8-K
Regulation FD Disclosure
24 Mar 23
8-K
Departure of Directors or Certain Officers
21 Mar 23
8-K
Completion of Acquisition or Disposition of Assets
15 Mar 23
8-K
Entry into a Material Definitive Agreement
24 Feb 23
8-K
Regulation FD Disclosure
23 Feb 23
8-K
Other Events
17 Feb 23
8-K
Departure of Directors or Certain Officers
27 Jan 23
Registration and prospectus
15-12G
Securities registration termination
13 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jun 23
POSASR
Automatic shelf registration (post-effective amendment)
13 Jun 23
POS AM
Prospectus update (post-effective amendment)
13 Jun 23
25-NSE
Exchange delisting
3 Mar 23
S-3
Shelf registration
10 May 22
S-8
Registration of securities for employees
14 Jan 22
FWP
Free writing prospectus
15 Nov 21
424B5
Prospectus supplement for primary offering
15 Nov 21
SC TO-I/A
Issuer tender offer statement (amended)
16 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 22
DEF 14A
Definitive proxy
25 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
PRE 14A
Preliminary proxy
12 Apr 21
DEFA14A
Additional proxy soliciting materials
3 Jun 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
PRE 14A
Preliminary proxy
17 Apr 20
DEFA14A
Additional proxy soliciting materials
18 Apr 19
Other
EFFECT
Notice of effectiveness
20 Jun 23
EFFECT
Notice of effectiveness
20 May 22
CORRESP
Correspondence with SEC
17 May 22
UPLOAD
Letter from SEC
13 May 22
EFFECT
Notice of effectiveness
23 Mar 21
CORRESP
Correspondence with SEC
18 Mar 21
UPLOAD
Letter from SEC
29 Jan 21
EFFECT
Notice of effectiveness
4 Apr 19
CORRESP
Correspondence with SEC
1 Apr 19
CORRESP
Correspondence with SEC
1 Apr 19
Ownership
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 23
SC 13G/A
Frazier Life Sciences Public Fund, L.P.
14 Feb 23
SC 13G/A
Deep Track Capital, LP
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13D/A
Sibling Capital Ventures LLC
16 Dec 22
4
Change in insider ownership
25 Nov 22
4
David P Bonita
25 Nov 22
SC 13D/A
ORBIMED ADVISORS LLC
25 Nov 22
4
Robert J Alpern
25 Nov 22
4
Robert J Alpern
22 Nov 22